SCHEMBL9016629

SCHEMBL9016629

CSc1cn(C)c(O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13637824 0.74
SCHEMBL8655068 0.67 ALDH1A1 (0.31)
SCHEMBL15034720 0.57 MAPT (0.54)
SCHEMBL11443292 0.56
SCHEMBL11641704 0.55 CYP1A2 (0.50)
SCHEMBL24156967 0.53 MAPT (0.34)
SCHEMBL11527821 0.53 MAPT (0.34)
SCHEMBL8779829 0.53 CCR1 (0.39)
SCHEMBL11466443 0.52
SCHEMBL9089789 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748315-A1 USE OF IMIDAZOLE DERIVATIVES FOR TREATING DISORDERS INVOLVING ANGIOTENSIN RECEPTORS AT 1? AND AT 2?, CERTAIN SUCH PRODUCTS, PREPARATION THEREOF, USE THEREOF AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME ROUSSEL UCLAF (FR) 1996-12-18 EP disclosed